AMP 2025: DNAe to unveil latest data from world’s first NGS-based, fully automated sample-to-result diagnostic platform

Poster presentations will preview new data from breakthrough bloodstream infection detection and oncology tests running on first-of-its-kind Lilia-SEQ™ platform LONDON and CARLSBAD, Calif., Nov. 5, 2025 /PRNewswire/ — DNAe, the Next-Generation Sequencing (NGS) company developing a…